Eye and Vision: review time and acceptance speed

ISSN 2326-0254 · BioMed Central · Medicine

Half of the articles Eye and Vision accepted in 2024 were accepted within 173 days of submission (n = 50); the middle half took 147–190 days.

Submission → acceptance (2024)
173 days median
middle half 147–190 · n = 50
Acceptance → online
30 days median
middle half 24–39 · n = 50
Change since 2022
Slower than 2022: the median rose from 152 to 173 days (90% CI +3 to +39 days).
Open access · fees
Open access (DOAJ) · $2,790

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Eye and Vision take to accept a paper?

days0601201802402020: middle half 134–194 days1672020n=522022: middle half 139–181 days1522022n=502024: middle half 147–190 days1732024n=50
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
2024501471731900.0%0%
2022501391521810.0%0%
2020521341671945.8%0%

Distribution in 2024

0–29 days: 0% (0 articles)030–59 days: 0% (0 articles)3060–89 days: 0% (0 articles)6090–119 days: 10% (5 articles)90120–149 days: 18% (9 articles)120150–179 days: 34% (17 articles)150180–209 days: 26% (13 articles)180210–239 days: 10% (5 articles)210240–269 days: 2% (1 articles)240270–299 days: 0% (0 articles)270300–329 days: 0% (0 articles)300330–359 days: 0% (0 articles)330360+ days: 0% (0 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2900.0%
30–5900.0%
60–8900.0%
90–119510.0%
120–149918.0%
150–1791734.0%
180–2091326.0%
210–239510.0%
240–26912.0%
270–29900.0%
300–32900.0%
330–35900.0%
360+00.0%

From acceptance to online publication

After acceptance, half of the 2024 articles appeared online within 30 days (middle half 24–39 days, n = 50).

From submission to online publication, the median was 200 days (middle half 179–228 days, n = 50).

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Open access (listed in DOAJ). Listed APC: $2,790 (DOAJ).

OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJYes (DOAJ record)
Articles indexed for MEDLINE in 2024None found (the journal may be in PubMed through PubMed Central instead)
Retractions0 retracted articles among 237 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission0.0% of 2024 articles
Publication volume47 articles added to PubMed in 2024.

Topics and scope

Medicine journalsRadiology, Nuclear Medicine and Imaging journalsOphthalmology journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2024 figures are compared with the 2024 median of Eye and Vision, 173 days.

Paid APC medianDOAJMEDLINE
Journal of Current Ophthalmology129 (2024, n = 58)No fee (DOAJ)YesNo
Clinical ophthalmology92 (2024, n = 394)$3,940$2,868 (8 payments)YesNo
International Journal of Ophthalmology153 (2024, n = 339)$1,800YesNo
BMC Ophthalmology153 (2024, n = 548)$3,090$2,165 (6 payments)YesYes
Journal of Ophthalmic and Vision Research209 (2024, n = 55)$300YesNo
Ophthalmology and Therapy51 (2024, n = 190)$7,675YesNo
International Ophthalmology165 (2024, n = 377)≈$3,790NoYes

Frequently asked questions

How long does Eye and Vision take to accept a paper?

Half of the articles Eye and Vision accepted in 2024 were accepted within 173 days of submission (n = 50); the middle half took 147–190 days. Based on dates in PubMed for accepted articles only.

How long after acceptance are Eye and Vision articles published online?

Half of the articles accepted in 2024 appeared online within 30 days of acceptance (n = 50).

Does Eye and Vision charge an article processing charge (APC)?

Listed APC: $2,790 (DOAJ).

Sources and method

Journal identity: ISSN-L 2326-0254; NLM ID 101664982; OpenAlex record. Speed figures use 50 articles accepted in 2024 with valid dates; excluded records for that year: none.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.